SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
SEC Accession No. 0001193805-21-001179
Filing Date
2021-08-13
Accepted
2021-08-13 17:24:19
Documents
5
Effectiveness Date
2021-08-13

Document Format Files

Seq Description Document Type Size
1 e620874_f6ef-mereo.htm F-6EF 55749
2 e620874_ex99-b.htm EX-99.(B) 41445
3 e620874_ex99-d.htm EX-99.(D) 6583
4 e620874_ex99-e.htm EX-99.(E) 3312
5 GRAPHIC logo.jpg GRAPHIC 18700
  Complete submission text file 0001193805-21-001179.txt   134495
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6EF

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Subject) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6EF | Act: 33 | File No.: 333-258824 | Film No.: 211173440
SIC: 2834 Pharmaceutical Preparations